Positive context积极背景
Stocks股票 / Health Care / ZTS
Zoetis · Health Care
ZTS US listed · USD美股 · 美元
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.硕腾公司（Zoetis Inc.，发音为/zō-EH-tis/）是一家美国制药公司，是全球最大的宠物和牲畜药品及疫苗生产商。
Large cap大盘 · $34B
Health Care
Mixed profile混合特征
$81.03
Regular quote常规时段报价
-$0.97 · -1.18%
Extended quote unavailable. Showing the regular quote.盘前盘后报价暂不可用，现显示常规时段报价。
Pre-market盘前
·
52w low52周低 $68.22high高 $147
Extended — wait for a pullback过度拉伸 — 等待回撤
The low is already in and price has run. Wait for a pullback; hold if you're long.低点已经形成、价格已经拉升。等待回调再入场；若已持有可继续持有。
As of 2026-10-26截至 2026-10-26
Company news公司新闻
The latest reporting最新报道
One story, with the reporting behind it.将同一事件汇总，保留各来源报道。
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-10-26
Momentum (RSI 14)动量（RSI 14）
69
Elevated偏高
vs 50-day average相对50日均线
+8.6% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
-14.2% below下方
Long trend down长期向下
Volatility波动率
31th percentile第31百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-11-0511
Estimates being cut预期下调
Beat in 3 of last 4 quarters近 4 季中 3 季超预期
Post-earnings drift: +5.0% (20d)财报后漂移：+5.0%（20日）
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 1.8%
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | ZTS | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 12.88x | 31.50 | |
| P/B市净率 | 10.08x | 3.57 | |
| P/S市销率 | 3.64x | 3.19 | |
| Earnings yield盈利收益率 | 7.76% | 2.37 | |
| FCF yield自由现金流收益率 | 6.63% | 3.88 | |
| Shareholder yield股东收益率 | 9.40% | 1.83 | |
| P/FCF市值/自由现金流 | 15.08x | 23.56 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
$9.5B2025
20202025
5-yr growth5年复合增速 7.2%
Earnings per share每股收益
$6.022025
20202025
5-yr growth5年复合增速 12.0%
Free cash flow自由现金流
$2.3B2025
20202025
Net margin净利率
28.2%
FCF margin自由现金流利润率
30.7%
Balance-sheet quality财务体质 6/9
Bankruptcy risk: safe zone破产风险：安全区
Return on equity股本回报率 78%
Clean稳健
Leverage杠杆
Current ratio流动比率3.03
Capital allocation资本配置
Buybacks (TTM)回购（TTM）$3.2B
Stock-based comp股权薪酬$83.0M
Share count change (1y)股数变化（1年）-5.3%
Debt coming due到期债务
FY2025 10-KIn the 12-month bucket following fiscal period end 2025-12-31, it reported $0 due — about 0% of its disclosed principal.在财年期末 2025-12-31 之后12个月的区间内，已披露到期本金为 $0，约占其披露本金的 0%。
All maturity buckets are measured from fiscal period end 2025-12-31, not from today.所有到期区间均从财年期末 2025-12-31 起算，而非从今天起算。
First 12 months after period end报告期末之后首12个月
$0
Year 2第2年
$750.0M
Year 3第3年
$1.4B
Year 4第4年
$2.0B
Year 5第5年
$750.0M
After year 55年以后
not reported未披露
A cash-flow scenario is unavailable until the filing inputs are verified.报告数据核实前，现金流情景暂不可用。
Capital-need coverage is partial; incomplete or incompatible filing inputs are not combined.资本需求覆盖信息不完整；不会合并不完整或不兼容的报告数据。
Any available cash-flow scenario is context only. Missing or incompatible inputs are not replaced with zero or a financing forecast.可用现金流情景仅供参考；缺失或不兼容的输入不以零值或融资预测替代。
Sources and cash-flow calculation来源与现金流计算
Figures are XBRL facts from one filing — no two years are mixed. Filing数据取自同一份文件中的 XBRL 事实，不跨文件拼接。文件
0001555280-26-000011, period ending报告期截至 2025-12-31, unit单位 USD.
Cache acquired缓存获取时间: 2026-10-06T11:08:33.290400+00:00.
5/6 buckets reported.个区间有披露。
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwoLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThreeLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFourLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive— period_mismatch
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Sector / Theme行业/主题
Health Care (Equal-Weight) theme — #4 of 49 themes「医疗保健（等权）」主题 — 49 个主题中第 4 位
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
ZTS took relative-strength leadershipZTS 取得相对强弱领先
Options positioning期权持仓
as of last close截至上一收盘Market makers are net long gamma — price pinned near current level做市商净持有正伽玛，价格倾向于在当前水平附近震荡
Expected daily move预期日波动
±2.94%
Expected weekly move预期周波动
±6.58%
Gamma flip伽玛翻转位
$71
25d risk reversal25d风险逆转
-2.0%
Skew: balanced偏斜：balanced
Call and put walls are plotted on the Trade levels ladder →看涨/看跌期权墙已标注在「交易点位」阶梯上 →
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： +$0.9M net (3 buyers, 0 sellers)+$0.9M 净值（3 买家，0 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Soros Fund Management | B | New position新建仓 | 0.0% | 2026-06-30 |
| Polen Capital Management | C | trimtrim | 0.2% | 2026-06-30 |
Signal history信号历史
engine events引擎事件
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS. A daily bottoming setup did fire (swing low in, momentum turned up), but it's LATE — price is already extended above the cycle low (formed ~16 day(s) ago @ 69.1) and momentum is fading — the daily momentum is already rolling over. A momentum cross is a LAGGING confirmation: after a vertical run it only triggers once the move is mature, so the bottoming entry has already passed. This is a chase, not a fresh buy. Last cycle was left-translated (topped early) — a bearish structural tell止盈。日线筑底形态确实已经触发（摆动低点出现、动量转向上行），但为时已晚——价格已显著高于周期低点（约 16 天前形成 @ 69.1）且动量正在衰竭——日线动量已开始掉头向下。动量交叉属于滞后确认：在垂直拉升之后，只有当走势已经成熟时才会触发，因此筑底入场早已错过。这是追高，而非新的买入。 上一周期为左移结构（见顶偏早）——属于看空的结构性信号
Oct 22, 2026
ZTS took relative-strength leadershipZTS 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $82.00.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$82.00。
Oct 22, 2026
ZTS RSI reached overboughtZTS RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $82.00.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$82.00。
Oct 20, 2026
ZTS RSI reached overboughtZTS RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $80.04.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$80.04。
Oct 14, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Oct 13, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Oct 8, 2026
UNCONFIRMED TURN → BOTTOMING未确认转向 → 筑底中
BUY SETUP买入预备
Oct 6, 2026
ZTS daily MACD crossed upZTS 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $71.33.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$71.33。
Oct 5, 2026
DOWNTREND → UNCONFIRMED TURN下跌趋势 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Oct 5, 2026
ZTS StochRSI turned up from oversoldZTS StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $71.41.StochRSI重回20上方 — 下行动量趋缓的最早预警。$71.41。
Showing the last 15 of显示最近15条，共 118 signals条信号
Company profile公司档案
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.硕腾公司（Zoetis Inc.，发音为/zō-EH-tis/）是一家美国制药公司，是全球最大的宠物和牲畜药品及疫苗生产商。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Below market低于市场
Shareholder payout股东回报
Above market高于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Above market高于市场
Short interest空头兴趣
Below market低于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
- Receivables stretch
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（静态） | 12.9× | 31.5× | 91% |
| Price / Book市净率 | 10.1× | 3.6× | 12% |
| Price / Sales市销率 | 3.6× | 3.2× | 44% |
| Earnings yield盈利收益率 | 7.8% | 2.4% | 94% |
| Free-cash-flow yield自由现金流收益率 | 8.4% | 5.2% | 81% |
| Shareholder yield股东综合回报率 | 9.4% | 1.8% | 97% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
4/100 — weaker than most弱于多数
vs market, 3 months相对大盘（3个月）
71/100 — stronger than most强于多数
vs market, 6 months相对大盘（6个月）
10/100 — weaker than most弱于多数
vs market, 12 months相对大盘（12个月）
5/100 — weaker than most弱于多数
Rank in sector行业内排名
#175 / 175
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +2.1% | -0.4% |
| 1 Month近1月 | +13.2% | -1.0% |
| 3 Months近3月 | +7.5% | +3.1% |
| 6 Months近6月 | -30.7% | +7.0% |
| Year to date年初至今 | -35.1% | +12.1% |
| 1 Year近1年 | -44.0% | +14.4% |
Trading information交易信息
Beta vs market贝塔
0.56
Volatility rank波动率分位
31th pctile
Short interest空头占比
4.3% of float
Market cap市值
$34B
EPS (trailing)每股收益
$6.29
Off 52-week high距52周高点
-44.4%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $6.7B | $7.8B | $8.1B | $8.5B | $9.3B | $9.5B |
| EPS每股收益 | $3.42 | $4.27 | $4.49 | $5.07 | $5.47 | $6.02 |
| Free cash flow自由现金流 | $1.7B | $1.7B | $1.3B | $1.6B | $2.3B | $2.3B |
| Gross margin毛利率 | 69.2% | 70.4% | 69.6% | 70.0% | 70.6% | 71.8% |
| Net margin净利率 | 24.5% | 26.2% | 26.2% | 27.4% | 26.9% | 28.2% |
| FCF margin自由现金流利润率 | 25.1% | 22.3% | 16.4% | 19.0% | 24.8% | 24.1% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$9.5B
Net income净利润
$2.7B
Operating cash flow经营现金流
$2.9B
Total assets总资产
$15.5B
Shareholder equity股东权益
$3.4B
Long-term debt长期负债
$9.0B
Buybacks股票回购
$3.2B
Shares outstanding总股本
0.42B
Returns & growth回报与增长
Return on equity股本回报率
78.3%
Return on assets资产回报率
17.3%
Debt / assets负债/资产
58.4%
Profit growth利润增速
+7.5%
Asset growth资产增速
+8.8%
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量：应计利润接近同业中位
- Working capital: working capital roughly in line with sales营运资本：营运资本与销售大致同步
- Pricing power: gross margin +2.6pts over 6 years定价能力：毛利率 6 年上升 2.6 个百分点
- Capital discipline: investment near the peer median资本纪律：投资力度接近同业中位
- Balance sheet: Altman Z 3.91 — safe zone资产负债表：Altman Z 3.91——安全区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
69
RSI (2-day)RSI（2日）
56
vs 20-day average相对20日均线
+8.2%
vs 50-day average相对50日均线
+8.6%
vs 200-day average相对200日均线
-14.2%
Golden cross (50>200)金叉（50>200）
not in effect未生效
MACDMACD
above signal位于信号线上方
Timeframe alignment多周期共振
Daily日线
momentum up动能向上
3-day3日线
momentum up动能向上
Weekly周线
momentum up动能向上
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
86/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $1.87 | $1.84 | +1.6% |
| Mar 2026 | $1.53 | $1.61 | -5.0% |
| Dec 2025 | $1.48 | $1.40 | +5.7% |
| Sep 2025 | $1.70 | $1.62 | +4.9% |
Estimate revisions预期修正
Analysts covering覆盖分析师
15
Estimate direction预期调整方向
mostly cutting多数下调
Estimate change, 90 days预期变化（90天）
-11.4%
Net upgrades, 30 days净上调（30天）
-15
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Options — full detail期权持仓 — 完整明细
Dealer positioning map做市商持仓地图
Call wall看涨期权墙
$85
Put wall看跌期权墙
$75
Gamma flip伽玛翻转位
$71
Upside magnet上方磁吸位
$85
Downside magnet下方磁吸位
$75
Net dealer gamma做市商净伽玛
+$0.0B
Distance to flip距翻转位
+13.0%
Walls and magnets are strikes with heavy open interest — price often slows or gravitates there.期权墙与磁吸位是未平仓集中的行权价 — 价格常在附近减速或被吸引。
Volatility pricing波动率定价
Implied volatility (30d)隐含波动率（30天）
0%
25-delta risk reversal25-delta风险逆转
-2.0%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Soros Fund Management | B | New position新建仓 | 0.0% | $2M |
| Polen Capital Management | C | Trimming减持 | 0.2% | $23M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
2
Buying vs selling买入vs卖出
1 : 1
Quarterly trend季度趋势
{'direction': 'distributing', 'n_quarters': 11, 'holders_first': 2, 'holders_last': 1, 'holders_delta': -1, 'value_change_pct': -53.2, 'from_period': '2023-09-30', 'to_period': '2026-03-31', 'available_on': '2026-05-14', 'available_on_first': '2023-11-13', 'holders_series': [2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 1]}{'direction': 'distributing', 'n_quarters': 11, 'holders_first': 2, 'holders_last': 1, 'holders_delta': -1, 'value_change_pct': -53.2, 'from_period': '2023-09-30', 'to_period': '2026-03-31', 'available_on': '2026-05-14', 'available_on_first': '2023-11-13', 'holders_series': [2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 1]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
+$0.9M
Insider buyers vs sellers内部人买家vs卖家
3 : 0
Short interest空头占流通盘
4.3%
Days to cover回补天数
4.1
Short interest change空头变化
+6.0%
Recent fund flows近期基金流向
VanEck Morningstar Wide MoatVanEck Morningstar Wide Moat
accumulating持续增持
SPDR S&P PharmaceuticalsSPDR S&P Pharmaceuticals
accumulating持续增持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。